Insider filing · AORT
Marshall S. Stanton
SVP, Clinical & MD Affair
profile →
Artivion, Inc.
AORT · Healthcare · 59 filings in 24 months
ticker →
Marshall S. Stanton sold $656K of Artivion (AORT)
Executed Jun 13 2025, disclosed Jun 16 2025, 3 days later.
Value, as filed
$656K
23,053 sh across 2 lots
Executed
Jun 13 2025
the trade date, as filed
Disclosed
Jun 16 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMarshall S. Stanton (SVP, Clinical & MD Affair) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Artivion, Inc. (AORT). The largest single filing was $2.1M of AORT (47,376 sh across 4 lots, as filed), executed Nov 21 2025.
The name
AORTHealthcare · Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Marshall S. Stanton in AORT
AORTSALE
Artivion, Inc.
$2.1M47,376 sh across 4 lots
Exec Nov 21 2025
Filed Nov 24 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $525K
11,888 sh × $44.14
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $229K
4,993 sh × $45.86
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $114K
2,566 sh × $44.62
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $801K
18,200 sh × $44.02
Exec Aug 27 2025
Filed Aug 28 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $406K
13,764 sh × $29.50
Exec Jun 17 2025
Filed Jun 18 2025 · 5:30 PM ET AORTSALE Artivion, Inc. $307K
10,548 sh across 2 lots
Exec May 9 2025
Filed May 12 2025 · 5:30 PM ET